Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

USD 7,000

* Required Fields

USD 7,000

PAY BY INVOICE

Be the first to review this product

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.

Table of Contents

1. Executive Summary
Key Findings—Pharmaceutical CMO Market
Scope and Geographic Segmentation
Market Segmentation
Methodology
Market Engineering Measurements
Market Overview
Competitor Overview
Total Addressable Market
Industry Advancement
Global Manufacturing Footprint—Key CMO Companies
Transformation of Industry Ecosystem
Trends for the FDF CMO Market
Trends for the API and Intermediates CMO Market
Key Technology Trends—Preference for Disposable Technologies
Key Technology Trends—Rising Demand of Lyophilization
Key Investment Trends
Game-changing Companies
Customer Segment Revenue Contribution Analysis
8 Big Market Themes for Contract Manufacturing
2. Global CMO Market Landscape
Total Pharmaceutical CMO Market Revenue Forecast
API and Intermediates CMO Market Overview
FDF CMO Market Overview
Role of CMOs in the Pharmaceutical Manufacturing Value Chain
API and Intermediates and FDF Industry Ecosystem
Demand and Market Acceptance of Customers’ Products
Changing Business Model—Rise in Virtual Pharma
Virtual Pharma—Change Makers in Pharma and Biotech Outsourcing Ecosystem
Key Characteristics Influencing CMO Selection
New Business Models
Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market
Global CMO Key Market Trends
Key Technology Trends—Inclination towards Continuous Manufacturing
Key Technology Trends—Prominence of Gamma Sterilization
Key Technology Trends—Rising Acceptance of Process Analytical Technologies (PAT)
Key Market Drivers
Core competencies
Consolidation/ acquisitions
Increasing outsourcing volume by big pharma
Blockbuster drugs coming out of patent
Expanding services of CMOs
Increased adherence to a risk-sharing model will support virtual pharmaceutical
CDMO model
Key Market Restraints
Stringent regulatory requirements
Cost Pressure on pharma companies
Lack of venture capital (VC) funding for early-stage companies
Dependence on key starting materials and lack of substitutes
Lower unit volumes and new technologies
3. Competitive Playbook
Snapshot of Competitive Landscape
CMO Expansions in Products, Clinical Services, and Capacity Offerings
Differential Revenue Growth
Uncertainty Matrix—Mapping of Key CMO Industry Uncertainties
Possible Industry Overcapacity
10 Companies to Watch and Why
4. Key Merger, Acquisition, and Partnership Agreements of the Contract Manufacturing Markets
Key Mergers and Acquisitions
Notable Mergers and Acquisitions—CMO Industry on a Consolidation Spree
Key Merger, Acquisition, and Partnership Agreements
Key FDF CMO Segment Strategic Collaborations
Key API and Intermediates Segment Strategic Collaborations
5. Forecast and Trends
Market Engineering Measurements
Total Pharmaceutical CMO Market Revenue Forecast
Total Pharmaceutical CMO Market Percent Revenue Forecast by Region
Total Pharmaceutical CMO Market Revenue Forecast by Region
6. Total Pharmaceutical CMO Market Forecast by Service Type
Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type
Total Pharmaceutical CMO Market Revenue Forecast by Service Type
7. Global API and Intermediates CMO Market Breakdown
API and Intermediates CMO Market Overview
Value Chain of Pharmaceutical Manufacturing
Market Segmentation
API and Intermediates CMO Market Revenue Forecast
API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region
API CMO Market Percent Revenue Breakdown by Synthesis Route
API and Intermediates CMO Market Revenue Forecast by Synthesis Route
API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base
API and Intermediates CMO Market Revenue Breakdown by Customer Base
8. Global FDF CMO Market Breakdown
Market Segmentation
FDF CMO Market Percent Revenue Breakdown by Geographic Region
FDF CMO Market Percent Revenue Forecast by Dosage Form
FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status
FDF CMO Market Revenue Forecast
FDF CMO Market Percent Revenue Forecast by Dosage Form
FDF CMO Market Revenue Forecast by Dosage Form
9. Market Share and Competitive Analysis
Global FDF CMO Market Share Analysis
API and Intermediates CMO Market—Competitive Structure
Key CMO Breakdown by APIs and FDFs
10. United States Breakdown
Market Overview
Market Analysis
Market Engineering Measurements
US Pharmaceutical CMO Market Revenue Forecast
US Pharmaceutical CMO Market Revenue Forecast by Service Type
11. US API and Intermediates CMO Market
US API and Intermediates CMO Market Revenue Forecast
12. US FDF CMO Market Breakdown
US FDF CMO Market Revenue Forecast
US Solid Dose Formulations Segment Revenue Forecast
US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
US Injectable Dose Formulations Segment Revenue Forecast
Pricing Analysis
PESTLE Analysis
13. US—Key Companies to Watch
Patheon
Patheon—Major Partnerships and Agreements
Catalent
Catalent—Major Partnerships and Agreements
Baxter Biopharma Solutions
14. Western Europe Breakdown
Market Overview
Market Analysis
Market Engineering Measurements
Western European Pharmaceutical CMO Market Revenue Forecast
Western European Pharmaceutical CMO Market Revenue Forecast by Service Type
Western European FDF CMO Market Revenue Forecast by Dosage Form
15. Western Europe API and Intermediates CMO Market Breakdown
Western Europe API and Intermediates CMO Market Revenue Forecast
16. Western Europe FDF CMO Market Breakdown
Western Europe FDF CMO Market Revenue Forecast
Solid Dose Formulations Segment Revenue Forecast
Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Injectable Dose Formulations Segment Revenue Forecast
Pricing Analysis
PESTLE Analysis
17. Breakdown by Key Western Europe Countries
Market Segmentation for Western Europe Breakdown
18. Germany Breakdown
Germany FDF CMO Market Revenue Forecast
Germany FDF CMO Market Revenue Forecast by Dosage Form
Germany Solid Dose Formulations Segment Revenue Forecast
Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Germany Injectable Dose Formulations Segment Revenue Forecast
19. UK Breakdown
20. France Breakdown
21. Italy Breakdown
22. Spain Breakdown
23. Scandinavia Breakdown
24. Benelux Breakdown
25. Western Europe—Key Companies to Watch
Aenova
Aenova—Major Partnerships and Agreements
Famar
Famar—Major Partnerships and Agreements
Fareva
Fareva—Major Partnerships and Agreements
DTP Laboratories
DPT Laboratories—Major Partnerships and Agreements
Vetter Pharma
Vetter Pharma—Major Partnerships and Agreements
Consort Medical (Aesica/Bespak)
Consort Medical—Major Partnerships and Agreements
Recipharm
Recipharm—Major Partnerships and Agreements
26. APAC Breakdown
Market Overview
Market Engineering Measurements
APAC Pharmaceutical CMO Market Revenue Forecast
APAC Pharmaceutical CMO Market Revenue Forecast by Service Type
27. APAC API and Intermediates CMO Market Breakdown
APAC API and Intermediates CMO Market Revenue Forecast
28. APAC FDF CMO Market Breakdown
APAC FDF CMO Market Revenue Forecast
APAC FDF CMO Market Percent Revenue Forecast by Dosage Form
APAC FDF CMO Market Revenue Forecast by Dosage Form
Pricing Analysis
PESTLE Analysis
29. Breakdown by Key APAC Countries
Market Segmentation for APAC Breakdown
30. China Breakdown
Market Summary—China
China Pharmaceutical CMO Market Revenue Forecast
China Pharmaceutical CMO Market Revenue Forecast by Service Type
China API and Intermediates CMO Market Revenue Forecast
China FDF CMO Market Revenue Forecast
China FDF CMO Market Revenue Forecast by Dosage Form
China Solid Dose Formulations Segment Revenue Forecast
China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
China Injectable Dose Formulations Segment Revenue Forecast
China Segment Discussion
Huapont Pharm Co., Ltd
Huapont Pharm Co., Ltd—Major Partnerships and Agreements
31. India Breakdown
Market Summary—India
India Pharmaceutical CMO Market Revenue Forecast
India Pharmaceutical CMO Market Revenue Forecast by Service Type
India API and Intermediates CMO Market Revenue Forecast
India FDF CMO Market Revenue Forecast
India FDF CMO Market Revenue Forecast by Dosage Form
India Solid Dose Formulations Segment Revenue Forecast
India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
India Injectable Dose Formulations Segment Revenue Forecast
Dr. Reddy’s Laboratories—Custom Pharma Services
Dr. Reddy’s Laboratories Custom Pharma Services—Major Partnerships and Agreements
32. Japan Breakdown
Market Summary—Japan
Japan Pharmaceutical CMO Market Revenue Forecast
Japan Pharmaceutical CMO Market Revenue Forecast by Service Type
Japan API and Intermediates CMO Market Revenue Forecast
Japan FDF CMO Market Revenue Forecast
Japan FDF CMO Market Revenue Forecast by Dosage Form
Japan Solid Dose Formulations Segment Revenue Forecast
Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Japan Injectable Dose Formulations Segment Revenue Forecast
Nipro Pharma Corporation
Nipro Pharma Corporation—Custom Pharma Services
Nipro Pharma Corporation—Major Partnerships and Agreements
33. The Last Word—Strategic Considerations for Staying on Growth Trajectory
Major Growth Opportunities
Global API Outsourcing Scenario
Growth Opportunities in API Contract Manufacturing
Emerging CMO Business Model
Risk Sharing Model—Achievable by Sharing the Following Resources
Various Differentiation Strategies to Drive Long-term Profitability of CMOs
Global Pharmaceutical CMO Market—Final Word
Legal Disclaimer
34. Appendix
Market Engineering Methodology
List of Other Key Companies Included in This Research Service

Infographic



List of Figures & Charts

1. Total Pharmaceutical CMO Market: Global Manufacturing Footprint, Global, 2015
2. Total Pharmaceutical CMO Market: Key Investment Trends, Global, 2012–2015
3. Total Pharmaceutical CMO Market: Game-changing Companies, Global, 2015
4. Total Pharmaceutical CMO Market: Comparative Capability Analysis of Key Participants, Global, 2015
5. Total Pharmaceutical CMO Market: Key Market Drivers, Global, 2016–2020
6. Total Pharmaceutical CMO Market: Key Market Restraints, Global, 2016–2020
7. Total Pharmaceutical CMO Market: Roles of CMOs in the Drug Development Process, Global, 2015
8. Total Pharmaceutical CMO Market: CMO Expansions, Global, 2011–2016
9. FDF CMO Market: Industry Capacity Analysis by Product Segment, Global, 2015
10. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, 2012–2016
11. Total Pharmaceutical CMO Market: Key Merger, Acquisition, and Partnership Agreements, Global, 2014–2016
12. Total FDF CMO Market: Key Mergers and Acquisitions, Global, 2016
13. Total API and Intermediates CMO Market: Key Mergers and Acquisitions, Global, 2015
14. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
15. Total Pharmaceutical CMO Market: Revenue Forecast by Region, Global, 2012–2020
16. Total Pharmaceutical CMO Market: Revenue Forecast by Service Type, Global, 2012–2020
17. FDF CMO Market: Revenue Forecast by Dosage Form, Global, 2012–2020
18. FDF CMO Market: Pricing Analysis, Global, 2015
19. FDF CMO Market: Market Share Analysis, Global, 2015
20. API and Intermediates CMO Market: Competitive Structure, Global, 2015
21. Total Pharmaceutical CMO Market: Key CMO Breakdown by API and FDF, Global, 2015
22. Pharmaceutical CMO Market: Market Engineering Measurements, US, 2015
23. FDF CMO Market: Pricing Analysis, US, 2015
24. Patheon—Major Partnerships and Agreements, Global, 2012–2015
25. Catalent—Major Partnerships and Agreements, Global, 2015–2016
26. Pharmaceutical CMO Market: Market Engineering Measurements, Western Europe, 2015
27. FDF CMO Market: Pricing Analysis, Western Europe, 2015
28. Aenova—Major Partnerships and Agreements, Global, 2012–2013
29. Famar—Major Partnerships and Agreements, Global, 2013–2016
30. Fareva—Major Partnerships and Agreements, Global, 2012 and 2015
31. DPT Laboratories—Major Partnerships and Agreements, Global, 2013, 2014, and 2016
32. Vetter Pharma—Major Partnerships and Agreements, Global, 2015
33. Consort Medical—Major Partnerships and Agreements, Global, 2011, 2013, and 2016
34. Recipharm—Major Partnerships and Agreements, Global, 2014–2016
35. Pharmaceutical CMO Market: Market Engineering Measurements, APAC, 2015
36. FDF CMO Market: Revenue Forecast by Dosage Form, APAC, 2012–2020
37. FDF CMO Market: Pricing Analysis, APAC, 2015
38. Huapont Pharm—Major Partnerships and Agreements, Global, 2007 and 2013
39. Dr. Reddy’s Laboratories—Major Partnerships and Agreements, Global, 2012, 2014, and 2015
40. Nipro Pharma Corporation—Major Partnerships and Agreements, Global, 2012 and 2014
41. Total Pharmaceutical CMO Market: Differentiation Strategies to Improve CMO Profitability, Global, 2015


1. Total Pharmaceutical CMO Market: Regional Market Share, Global, 2015
2. Total Pharmaceutical CMO Market: Market Segmentation, Global, 2015
3. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
4. Total Pharmaceutical CMO Market: FDF CMO Trends, Global 2015
5. Total Pharmaceutical CMO Market: API and Intermediates CMO Trends, Global 2015
6. Total Pharmaceutical CMO Market: Customer Segment Revenue Contribution to CMOs, Global, 2015
7. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
8. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
9. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2012–2020
10. FDF CMO Market: Revenue Breakdown by Geographic Region, Global, 2012–2020
11. FDF CMO Market: Percentage Segment Breakdown, Global, 2015
12. Pharmaceutical Manufacturing Market: Role of CMOs in Value Chain, Global, 2015
13. Total Pharmaceutical CMO Market: Factors that Adversely Affect Demand for Customer Products, Global, 2015
14. Total Pharmaceutical CMO Market: Virtual Outsourcing Model, 2015
15. Pharmaceutical CMO Market: Key Characteristics Influencing CMO Selection, Global, 2015
16. Total Pharmaceutical CMO Market: Growth Drivers and Contribution, Global, 2015
17. Total Pharmaceutical CMO Market: Map of Key CMO Industry Uncertainties, Global, 2015
18. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, <2001–2016
19. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
20. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
21. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Region, Global, 2012–2020
22. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
23. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
24. API and Intermediates CMO Market: Market Segmentation, Global, 2015
25. API and Intermediates CMO Market: Revenue Forecast, Global, 2012–2020
26. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
27. API and Intermediates CMO Market: Percent Revenue Breakdown by Synthesis Route, Global, 2015–2020
28. API and Intermediates CMO Market: Revenue Forecast by Synthesis Route, Global, 2012–2020
29. API and Intermediates CMO Market: Percent Revenue Breakdown by Customer Base, Global, 2015–2020
30. API and Intermediates CMO Market: Revenue Forecast by Customer Base, Global, 2012–2020
31. FDF CMO Market: Market Segmentation, Global, 2015
32. FDF CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
33. FDF CMO Market: Percent Revenue Breakdown by Segments, Global, 2015
34. FDF CMO Market: Percent Revenue Forecast Breakdown by Segments, Global, 2020
35. FDF CMO Market: Percent Revenue Breakdown by Patent Exclusivity Status, Global, 2015
36. FDF CMO Market: Revenue Forecast, Global, 2012–2020
37. FDF CMO Market: Percent Revenue Forecast by Dosage Form, Global, 2012–2020
38. FDF CMO Market: Market Share by Company, Global, 2015
39. Pharmaceutical CMO Market: Revenue Forecast, US, 2012–2020
40. Pharmaceutical CMO Market: Revenue Forecast by Service Type, US, 2012–2020
41. API and Intermediates CMO Market: Revenue Forecast, US, 2012–2020
42. FDF CMO Market: Revenue Forecast, US, 2012–2020
43. Solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
44. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
45. Injectable Dose Formulations Segment: Revenue Forecast, US, 2012–2020
46. Pharmaceutical CMO Market: Revenue Forecast, Western Europe, 2012–2020
47. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Western Europe, 2012–2020
48. FDF CMO Market: Revenue Forecast Finished Dosage Form, Western Europe, 2012–2020
49. API and Intermediates CMO Market: Revenue Forecast, Western Europe, 2012–2020
50. FDF CMO Market: Revenue Forecast, Western Europe, 2012–2020
51. Solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
52. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
53. Injectable Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
54. FDF CMO Market: Revenue Forecast, Germany, 2012–2020
55. FDF CMO Market: Revenue Forecast by Dosage Form, Germany, 2012–2020
56. Solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
57. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
58. Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
59. FDF CMO Market: Revenue Forecast, UK, 2012–2020
60. FDF CMO Market: Revenue Forecast by Dosage Form, UK, 2012–2020
61. Solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
62. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
63. Injectable Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
64. FDF CMO Market: Revenue Forecast, France, 2012–2020
65. FDF CMO Market: Revenue Forecast by Dosage Form, France, 2012–2020
66. Solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
67. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
68. Injectable Dose Formulations Segment: Revenue Forecast, France, 2012–2020
69. FDF CMO Market: Revenue Forecast, Italy, 2012–2020
70. FDF CMO Market: Revenue Forecast by Dosage Form, Italy, 2012–2020
71. Solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
72. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
73. Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
74. FDF CMO Market: Revenue Forecast, Spain, 2012–2020
75. FDF CMO Market: Revenue Forecast by Dosage Form, Spain, 2012–2020
76. Solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
77. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
78. Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
79. FDF CMO Market: Revenue Forecast, Scandinavia, 2012–2020
80. FDF CMO Market: Revenue Forecast by Dosage Form, Scandinavia, 2012–2020
81. Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
82. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
83. Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
84. FDF CMO Market: Revenue Forecast, Benelux, 2012–2020
85. FDF CMO Market: Revenue Forecast by Dosage Form, Benelux, 2012–2020
86. Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
87. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
88. Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
89. Pharmaceutical CMO Market: Revenue Forecast, APAC, 2012–2020
90. Pharmaceutical CMO Market: Revenue Forecast by Service Type, APAC, 2012–2020
91. API and Intermediates CMO Market: Revenue Forecast, APAC, 2012–2020
92. FDF CMO Market: Revenue Forecast, APAC, 2012–2020
93. FDF CMO Market: Percent Revenue Forecast by Dosage Form, APAC, 2012–2020
94. Pharmaceutical CMO Market: PESTLE Analysis, APAC, 2015
95. Pharmaceutical CMO Market: Revenue Forecast, China, 2012–2020
96. Pharmaceutical CMO Market: Revenue Forecast by Service Type, China, 2012–2020
97. API and Intermediates CMO Market: Revenue Forecast, China, 2012–2020
98. FDF CMO Market: Revenue Forecast, China, 2012–2020
99. FDF CMO Market: Revenue Forecast by Dosage Form, China, 2012–2020
100. Solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
101. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
102. Injectable Dose Formulations Segment: Revenue Forecast, China, 2012–2020
103. Pharmaceutical CMO Market: Revenue Forecast, India, 2012–2020
104. Pharmaceutical CMO Market: Revenue Forecast by Service Type, India, 2012–2020
105. API and Intermediates CMO Market: Revenue Forecast, India, 2012–2020
106. FDF CMO Market: Revenue Forecast, India, 2012–2020
107. FDF CMO Market: Revenue Forecast by Dosage Form, India, 2012–2020
108. Solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
109. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
110. Injectable Dose Formulations Segment: Revenue Forecast, India, 2012–2020
111. Pharmaceutical CMO Market: Revenue Forecast, Japan, 2012–2020
112. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Japan, 2012–2020
113. API and Intermediates CMO Market: Revenue Forecast, Japan, 2012–2020
114. FDF CMO Market: Revenue Forecast, Japan, 2012–2020
115. FDF CMO Market: Revenue Forecast by Dosage Form, Japan, 2012–2020
116. Solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
117. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
118. Injectable Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
119. API Contract Manufacturing Market: Revenue by Region, 2012–2016
120. Pharmaceutical CMO Market: Emerging Business Models, 2016



Keyword1
pharmaceutical contract manufacturing market
Keyword2
contract manufacturing growth
Keyword3
pharmaceutical contract manufacturing market

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 02-Mar-2015

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.